Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1–CXCR1/2-pathway

Experiments were designed to determine if the vasodilatory peptides maxadilan and pituitary adenylate cyclase-activating peptide (PACAP-38) may cause plasma leakage through activation of leukocytes and to what extent these effects could be due to PAC1 and CXCR1/2 receptor stimulation. Intravital mic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Svensjö, Erik, Saraiva, Elvira M., Amendola, Rafael Silveira, Barja-Fidalgo, Christina, Bozza, Marcelo T., Lerner, Ethan A., Teixeira, Mauro M., Scharfstein, Julio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694432/
https://ncbi.nlm.nih.gov/pubmed/22036674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mvr.2011.10.003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg